41.44
price down icon0.52%   -0.216
 
loading

Xoma Royalty Corp 주식(XOMA)의 최신 뉴스

pulisher
May 05, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

May 05, 2026
pulisher
May 01, 2026

XOMA (XOMA) holders offered $39 cash plus CVRs in Ligand buyout - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Ligand Pharmaceuticals Launches Takeover Plan at XOMA Royalty Corporation with 47.0% Stake - TradingView

May 01, 2026
pulisher
May 01, 2026

This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday - Sahm

May 01, 2026
pulisher
Apr 30, 2026

[SCHEDULE 13G] XOMA Royalty Corp Passive Investment Disclosure (>5%) - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

H.C. Wainwright cuts XOMA stock rating on Ligand acquisition - Investing.com

Apr 30, 2026
pulisher
Apr 30, 2026

HC Wainwright & Co. downgrades XOMA Royalty (XOMA) - MSN

Apr 30, 2026
pulisher
Apr 29, 2026

BVF group backs XOMA Royalty Corp (XOMA) merger with 21.4% locked-up stake - Stock Titan

Apr 29, 2026
pulisher
Apr 29, 2026

LGND: XOMA Buy Adds 100+ Assets - Yahoo Finance

Apr 29, 2026
pulisher
Apr 28, 2026

XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire

Apr 28, 2026
pulisher
Apr 28, 2026

XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm - GlobeNewswire Inc.

Apr 28, 2026
pulisher
Apr 28, 2026

Ligand to acquire XOMA Royalty - The Pharma Letter

Apr 28, 2026
pulisher
Apr 28, 2026

XOMA Royalty (XOMA) Moves 10.7% Higher: Will This Strength Last? - Yahoo Finance

Apr 28, 2026
pulisher
Apr 27, 2026

Ligand Pharmaceuticals to Buy XOMA Royalty for $39/Share, Lifts 2026 Guidance and EPS Outlook - MarketBeat

Apr 27, 2026
pulisher
Apr 27, 2026

BlackRock (NASDAQ: XOMA) reports 5.4% stake in XOMA Royalty Corp - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

XOMA (XOMA) closes Generation Bio acquisition, details cash-plus-CVR terms and LNP assets - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders? - The Malaysian Reserve

Apr 27, 2026
pulisher
Apr 27, 2026

HC Wainwright & Co. maintains XOMA Royalty (XOMA) buy recommendation - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Promising Biotech Stocks To Watch TodayApril 27th - MarketBeat

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand Bets On Royalty Growth With XOMA Buyout Worth Over $700 Million - Benzinga

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand Is Buying Xoma Royalty For $739 Million In Cash - Finimize

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand Pharmaceuticals Incorporated entered into a definitive agreement to acquire XOMA Royalty Corporation for approximately $470 million from BVF Partners L.P. and others. - marketscreener.com

Apr 27, 2026
pulisher
Apr 27, 2026

Ademi LLP Investigates XOMA for Possible Violations - Intellectia AI

Apr 27, 2026
pulisher
Apr 27, 2026

Xoma Royalty Corp - Reuters

Apr 27, 2026
pulisher
Apr 27, 2026

XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 27, 2026
pulisher
Apr 27, 2026

Ademi LLP Investigates Whether XOMA Royalty Corporation Is Obtaining a Fair Price for Public Shareholders - Moomoo

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand (Nasdaq: LGND) to acquire XOMA Royalty in $739M, EPS‑accretive deal - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand Pharmaceuticals buying Xoma Royalty for $739 million - Yahoo Finance

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand Pharmaceuticals to Acquire XOMA Royalty for $739 Million, Expanding Biopharma Royalty Portfolio and Boosting 2026 EPS Guidance - Minichart

Apr 27, 2026
pulisher
Apr 27, 2026

XOMA Royalty to Be Acquired by Ligand in $39-Per-Share Cash Deal Plus CVRs - TradingView

Apr 27, 2026
pulisher
Apr 27, 2026

XOMA Stock Alert: Halper Sadeh LLC is Investigating Whether XOMA Royalty Corporation is Obtaining a Fair Price for its Shareholders - Business Wire

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand to buy XOMA Royalty (Nasdaq: XOMA) in $739M cash and CVR deal - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

XOMA Royalty: Transaction Is Expected to Close in the 3Q of 2026 >XOMA - Moomoo

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand to acquire XOMA Royalty for $739 million in cash - Investing.com

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand to acquire XOMA Royalty for $739 million in cash By Investing.com - Investing.com Australia

Apr 27, 2026
pulisher
Apr 27, 2026

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator - The Manila Times

Apr 27, 2026
pulisher
Apr 24, 2026

XOMA Stock Price, Quote & Chart | XOMA ROYALTY CORPORATION (NASDAQ:XOMA) - ChartMill

Apr 24, 2026
pulisher
Apr 23, 2026

XOMA Royalty (NASDAQ:XOMA) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Apr 23, 2026
pulisher
Apr 22, 2026

XOMA (XOMA) CFO converts 11,538 Performance Stock Units into common shares - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

XOMA (XOMA) legal chief converts 3,370 PSUs into common shares - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

XOMA (XOMA) CEO Owen Hughes exercises 10,568 PSUs and updates holdings - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

XOMA (XOMA) CIO boosts direct common holdings via 3,737 PSU conversion - Stock Titan

Apr 22, 2026
pulisher
Apr 22, 2026

XOMA Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 22, 2026
pulisher
Apr 22, 2026

XOMA ROYALTY CORPXOMA 8 3/8 PERP (NASDAQ:XOMAO) Checks All Eight Boxes in Navellier’s Little Book Growth Screen - ChartMill

Apr 22, 2026
pulisher
Apr 15, 2026

XOMA (XOMA) CFO exercises 4,000 PSUs, 1,632 shares withheld for taxes - Stock Titan

Apr 15, 2026
pulisher
Apr 15, 2026

XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 15, 2026
pulisher
Apr 14, 2026

XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN

Apr 14, 2026
pulisher
Apr 13, 2026

Published on: 2026-04-13 23:42:40 - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World

Apr 11, 2026
pulisher
Apr 11, 2026

GBIO SEC FilingsGeneration Bio Co. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 11, 2026
pulisher
Apr 10, 2026

Retail Surge: Is now the right time to enter XOMA Royalty Corporation2026 Fundamental Recap & Real-Time Buy Signal Alerts - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 08, 2026

XOMA Royalty (NASDAQ:XOMA) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Apr 08, 2026
pulisher
Apr 06, 2026

Growth Recap: What is the next catalyst for XOMA Royalty CorporationRate Hike & Weekly Momentum Stock Picks - baoquankhu1.vn

Apr 06, 2026
pulisher
Apr 03, 2026

XOMA shares climb after Q4 results top forecasts on strong royalty income - MSN

Apr 03, 2026
pulisher
Apr 03, 2026

XOMA Stock Analysis: XOMA Royalty Corporation 0.30% Dip at $32.98 Deep Dive - Cổng thông tin điện tử tỉnh Lào Cai

Apr 03, 2026
$28.50
price up icon 0.78%
$50.76
price up icon 2.57%
$92.69
price down icon 3.01%
$138.73
price down icon 1.11%
$147.88
price down icon 0.02%
ONC ONC
$305.60
price up icon 2.86%
자본화:     |  볼륨(24시간):